Published in Lancet on October 10, 1992
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76
Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13
Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95
Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81
Microchimerism of maternal origin persists into adult life. J Clin Invest (1999) 2.35
Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31
Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination. Am J Transplant (2011) 2.26
Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med (1995) 1.88
Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells (1995) 1.83
Transplantation tolerance, microchimerism, and the two-way paradigm. Theor Med Bioeth (1998) 1.67
Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice. Blood (2009) 1.63
Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs. Transplantation (2012) 1.63
The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56
Drug development and testing in relation to cell migration and chimerism. Transplant Proc (1993) 1.52
Split tolerance induced by orthotopic liver transplantation in mice. Transplantation (1994) 1.52
Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med (2004) 1.34
Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. Transplant Proc (1994) 1.29
Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant Proc (1995) 1.24
Transplantation tolerance through mixed chimerism. Nat Rev Nephrol (2010) 1.17
Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. Am J Pathol (1993) 1.13
Tolerance to noninherited maternal antigens in mice and humans. Curr Opin Organ Transplant (2009) 1.09
Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc (1993) 1.08
Progress in renal transplantation. A single center study of 3359 patients over 25 years. Ann Surg (1995) 1.07
Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Liver Transpl (2000) 1.07
Combined bone marrow and whole organ transplantation from the same donor. Transplant Proc (1994) 1.02
Recipient outcomes after ABO-incompatible liver transplantation: a systematic review and meta-analysis. PLoS One (2011) 1.00
Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients. Ann Thorac Surg (1995) 0.98
Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res (2007) 0.97
Biomarkers of transplantation tolerance: more hopeful than helpful? Front Immunol (2011) 0.94
The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93
Microchimerism: tolerance vs. sensitization. Curr Opin Organ Transplant (2011) 0.91
History of clinical transplantation. World J Surg (2000) 0.91
Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc (1996) 0.90
A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg (2000) 0.89
Graft-versus-host disease after liver transplantation. Clinics (Sao Paulo) (2011) 0.87
Migration of donor cells into the thymus is not essential for induction and maintenance of systemic tolerance after liver transplantation in the rat. Immunology (1995) 0.83
The future of transplantation: with particular reference to chimerism and xenotransplantation. Transplant Proc (1997) 0.83
Recent advances in hepatic transplantation at the University of Pittsburgh. Clin Transpl (1993) 0.83
Correlation between post transplant maternal microchimerism and tolerance across MHC barriers in mice. Chimerism (2011) 0.83
Review of the early diagnoses and assessment of rejection in vascularized composite allotransplantation. Clin Dev Immunol (2013) 0.83
Bidirectional alloreactivity: A proposed microchimerism-based solution to the NIMA paradox. Chimerism (2012) 0.82
Hematopoietic progenitor cell content of vertebral body marrow used for combined solid organ and bone marrow transplantation. Transplantation (1995) 0.82
Tolerance Induction in Liver. Int J Organ Transplant Med (2015) 0.81
Effects of donor bone marrow infusion in clinical lung transplantation. Ann Thorac Surg (2000) 0.80
The Future of Xenotransplantation. Ann Surg (1992) 0.80
Persistent molecular microchimerism induces long-term tolerance towards a clinically relevant respiratory allergen. Clin Exp Allergy (2012) 0.80
The dichotomous functions of passenger leukocytes in solid-organ transplantation. Adv Nephrol Necker Hosp (1995) 0.79
Propagation of cells expressing donor phenotype (MHC class I, II and Y-chromosome) from the bone marrow of murine liver allograft recipients in response to GM-CSF in vitro. Transplant Proc (1995) 0.78
Patterns of Immune Regulation in Rhesus Macaque and Human Families. Transplant Direct (2015) 0.78
Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol (2002) 0.78
The two-way paradigm of transplantation immunology. Clin Immunol Immunopathol (1996) 0.78
Augmentation of Recipient Adaptive Alloimmunity by Donor Passenger Lymphocytes within the Transplant. Cell Rep (2016) 0.77
Female gender in the setting of liver transplantation. World J Transplant (2014) 0.77
Primate models in organ transplantation. Cold Spring Harb Perspect Med (2013) 0.77
Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. Clin Transpl (1994) 0.76
The birth of clinical organ transplantation. J Am Coll Surg (2001) 0.76
The current status of hepatic transplantation at the University of Pittsburgh. Clin Transpl (1995) 0.76
Xenobiotics, chimerism and the induction of tolerance following organ transplantation. Ther Immunol (1994) 0.76
Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival. Chimerism (2013) 0.76
The role of cell migration and microchimerism in the induction of tolerance after solid organ transplantation. Postgrad Med J (1997) 0.75
The Role of Cell Migration and Chimerism in Organ Transplant Acceptance and Tolerance Induction. Transplant Sci (1993) 0.75
Prevention of Transplant Rejection: Can Tolerance be Achieved with Immunosuppressive Treatment? Clin Immunother (1996) 0.75
Chimerism after Whole Organ Transplant. Guthrie J Donald Guthrie Found Med Res (1993) 0.75
On the crossroad between tolerance and posttransplant lymphoma. Curr Opin Organ Transplant (1997) 0.75
Aspects of liver transplant pathology with emphasis on rejection and its mechanisms. J Clin Pathol (1994) 0.75
Immunological considerations in in utero hematopoetic stem cell transplantation (IUHCT). Front Pharmacol (2015) 0.75
The basis of allograft acceptance. Forum (Genova) (1997) 0.75
Current perspectives of transplantation immunology via the intestine. Transplant Proc (1996) 0.75
The bidirectional paradigm of transplant immunology. Ann N Y Acad Sci (1995) 0.75
The CD8 T-cell response during tolerance induction in liver transplantation. Clin Transl Immunology (2016) 0.75
Host stem cells repopulate liver allografts: reverse chimerism. Chimerism (2012) 0.75
Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients. Pediatr Nephrol (1995) 0.75
Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24
Induction of immunological tolerance by porcine liver allografts. Nature (1969) 5.89
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum (1969) 2.80
PCR amplification of chromosome-specific alpha satellite DNA: definition of centromeric STS markers and polymorphic analysis. Genomics (1991) 1.74
PCR detection of distal Yp sequences in an XX true hermaphrodite. Am J Med Genet (1991) 1.54
Drug development and testing in relation to cell migration and chimerism. Transplant Proc (1993) 1.52
Cell migration and chimerism--a unifying concept in transplantation--with particular reference to HLA matching and tolerance induction. Transplant Proc (1993) 1.40
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76
Bone marrow as a potential source of hepatic oval cells. Science (1999) 8.52
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Liver transplantation (1). N Engl J Med (1989) 4.53
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Baboon-to-human liver transplantation. Lancet (1993) 4.01
The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet (1997) 3.70
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18
Renal transplantation in baboons under FK 506. Surgery (1989) 3.17
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13
Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11
Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res (1999) 3.05
Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98
Liver transplantation (2). N Engl J Med (1989) 2.93
Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res (1997) 2.91
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91
Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia (2012) 2.85
Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84
Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation (1986) 2.82
The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81
Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81
Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75
THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun (1987) 2.75
Detection of Y chromosome sequences in Turner's syndrome by Southern blot analysis of amplified DNA. Lancet (1993) 2.65
A review of adult and pediatric post-transplant liver pathology. Pathol Annu (1987) 2.62
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50
Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med (1994) 2.48
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant (2013) 2.45
Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. Diabetes Care (2001) 2.37
Toxicology of FK-506 in the Lewis rat. Transplant Proc (1987) 2.37
Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31
FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29
Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. Transplant Proc (1991) 2.28
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25
Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature (1994) 2.25
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24
Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation (1992) 2.20
Transplantation milestones. Viewed with one- and two-way paradigms of tolerance. JAMA (1995) 2.20
Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc Natl Acad Sci U S A (1988) 2.19
Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation (1993) 2.17
A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant (2010) 2.14
Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation (1993) 2.14